| Thu, 05 Dec 2019 13:15:19: | Sage crushed by MOUNTAIN as phase 3 depression data fall short
|
| Thu, 05 Dec 2019 11:46:06: | Aurinia soars as phase 3 lupus study hits primary endpoint
|
| Thu, 05 Dec 2019 10:12:42: | How worms revealed a key protein in insulin synthesis and diabetes
|
| Thu, 05 Dec 2019 08:17:20: | Troubled Immunomedics tries again at FDA after rejection
|
| Wed, 04 Dec 2019 15:10:04: | Turning Merck's COPD drug against resistant prostate cancer
|
| Wed, 04 Dec 2019 13:25:42: | Omeros hits endpoint in pivotal stem cell transplant study
|
| Tue, 03 Dec 2019 15:42:51: | Pfizer Ventures helps gamma delta player ImCheck to $53M round
|
| Tue, 03 Dec 2019 15:38:14: | 'Positive surprise' for Biogen in lupus, but all eyes on CTAD data this week
|
| Tue, 03 Dec 2019 14:12:22: | Brii Biosciences nabs Icon, GSK veteran to lead new focus on neuroscience
|
| Tue, 03 Dec 2019 13:26:29: | Ardelyx's kidney disease drug hits goal in phase 3, teeing it up for FDA filing
|
| Tue, 03 Dec 2019 09:26:43: | Astellas inks $3B Audentes buyout to expand in gene therapy
|
| Mon, 02 Dec 2019 14:31:23: | From Covance CEO to short-lived LabCorp diagnostics lead, Ratliff lands at AMRI
|
| Mon, 02 Dec 2019 14:06:44: | Treating multiple sclerosis with the help of the gut microbiome
|
| Mon, 02 Dec 2019 13:35:09: | Analyst: Biogen's aducanumab is not getting approved absent a deus ex machina
|
| Mon, 02 Dec 2019 12:56:06: | Cyrus, the Broad team up to make in vivo CRISPR use safer
|
| Wed, 27 Nov 2019 14:19:24: | Stem cells don't repair injured hearts, but inflammation might, study finds
|
| Wed, 27 Nov 2019 13:28:38: | HLB defends itself in row over 'Best of ESMO 2019' claim
|
| Wed, 27 Nov 2019 09:08:48: | SEC charges ex-MiMedx execs with defrauding investors
|
| Tue, 26 Nov 2019 15:26:59: | How an abandoned Pfizer NASH drug gave rise to a Novartis-teamed follow-on
|
| Tue, 26 Nov 2019 10:40:34: | Teva forms academic R&D pacts to further biopharma strategy
|
| Tue, 26 Nov 2019 07:22:54: | La Jolla stops pivotal trial, parts company with CEO
|
| Mon, 25 Nov 2019 14:26:04: | Attacking drug-resistant infections by exploiting bacterial weak spots
|
| Mon, 25 Nov 2019 13:34:12: | Ferring, Blackstone spin out gene therapy with $570M in funding
|
| Mon, 25 Nov 2019 13:05:58: | U.K. government vows to double dementia funding if reelected
|
| Mon, 25 Nov 2019 12:50:51: | Hibernating animals offer genetic clues to obesity, metabolic diseases
|
